Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.69 USD | +0.32% | -1.88% | +28.85% |
May. 29 | MannKind Agrees to Cross License Deal With Pulmatrix | MT |
May. 29 | Pulmatrix, Inc. Announces Cross License Agreement and Transfer of Laboratory to MannKind Corporation | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.85% | 1.28B | |
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+1.43% | 22.48B | |
-9.54% | 18.32B | |
-42.28% | 16.33B | |
-18.92% | 15.31B | |
+6.19% | 14.08B | |
+28.83% | 11.74B |
- Stock Market
- Equities
- MNKD Stock
- News MannKind Corporation
- MannKind Receives FDA Fast Track Designation for its Potential Lung Disease Treatment